|
mutLBSgeneDB |
| |
| |
| |
| |
| |
| |
|
| Gene summary for UHRF2 |
 Gene summary |
| Basic gene Info. | Gene symbol | UHRF2 |
| Gene name | ubiquitin-like with PHD and ring finger domains 2, E3 ubiquitin protein ligase | |
| Synonyms | NIRF|RNF107|URF2 | |
| Cytomap | UCSC genome browser: 9p24.1 | |
| Type of gene | protein-coding | |
| RefGenes | NM_152896.2, NR_046386.1, | |
| Description | E3 ubiquitin-protein ligase UHRF2Np95-like ring finger proteinRING finger protein 107np95/ICBP90-like RING finger proteinnuclear protein 97nuclear zinc finger protein NP97ubiquitin-like PHD and RING finger domain-containing protein 2ubiquitin-like, | |
| Modification date | 20141207 | |
| dbXrefs | MIM : 615211 | |
| HGNC : HGNC | ||
| Ensembl : ENSG00000147854 | ||
| HPRD : 18257 | ||
| Vega : OTTHUMG00000019521 | ||
| Protein | UniProt: Q96PU4 go to UniProt's Cross Reference DB Table | |
| Expression | CleanEX: HS_UHRF2 | |
| BioGPS: 115426 | ||
| Pathway | NCI Pathway Interaction Database: UHRF2 | |
| KEGG: UHRF2 | ||
| REACTOME: UHRF2 | ||
| Pathway Commons: UHRF2 | ||
| Context | iHOP: UHRF2 | |
| ligand binding site mutation search in PubMed: UHRF2 | ||
| UCL Cancer Institute: UHRF2 | ||
| Assigned class in mutLBSgeneDB | C: This gene just belongs to mutLBSgenes. | |
| Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez |
| GO ID | GO Term | PubMed ID | GO:0006511 | ubiquitin-dependent protein catabolic process | 14741369 | GO:0016567 | protein ubiquitination | 14741369 | GO:0051865 | protein autoubiquitination | 14741369 | GO:0071158 | positive regulation of cell cycle arrest | 15178429 |
| Top |
| Ligand binding site mutations for UHRF2 |
| Lollipop-style diagram of mutations at LBS in amino-acid sequence. We represented ligand binding site mutations only. (You can see big image via clicking.)  : non-synonymous mutation on LBS, Circle size denotes number of samples. |
 |
| Cancer type specific mutLBS sorted by frequency |
| LBS | AAchange of nsSNV | Cancer type | # samples | H370 | Y369F | COAD | 1 | C736 | Q737R | COAD | 1 | C365 | V367M | LUAD | 1 | C756 | C756S | LUAD | 1 | C771 | R772Q | STAD | 1 | C733 | M732T | UCEC | 1 |
| cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma. |
| Top |
| Protein structure related information for UHRF2 |
| Relative protein structure stability change (ΔΔE) using Mupro 1.1 Mupro score denotes assessment of the effect of mutations on thermodynamic stability. (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability) |
 : nsSNV at non-LBS : nsSNV at LBS |
 |
| nsSNVs sorted by the relative stability change of protein structure by each mutation Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene. |
| LBS | AAchange of nsSNV | Relative stability change | C736 | Q737R | 0.11448557 | C733 | M732T | -1.6705412 | C756 | C756S | -1.607247 | H370 | Y369F | -1.1717432 | C771 | R772Q | -0.72505033 | C365 | V367M | -0.2184434 |
| (MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132) |
| Structure image for UHRF2 from PDB |
| Top |
| Differential gene expression and gene-gene network for UHRF2 |
| Differential gene expression between mutated and non-mutated LBS samples in all 16 major cancer types |
| Differential co-expressed gene network based on protein-protein interaction data (CePIN) |
| Top |
| Top |
| Phenotype information for UHRF2 |
| Gene level disease information (DisGeNet) |
| Disease ID | Disease name | # PubMed | Association type |
| Mutation level pathogenic information (ClinVar annotation) |
| Allele ID | AA change | Clinical significance | Origin | Phenotype IDs |
| Top |
| Pharmacological information for UHRF2 |
| Drug information targeting mutLBSgene (Approved drugs only) |
| Drug status | DrugBank ID | Name | Type | Drug structure |
| Gene-centered ligand-gene interaction network |
 |
| Ligands binding to mutated ligand binding site of UHRF2 go to BioLip |
| Ligand ID | Ligand short name | Ligand long name | PDB ID | PDB name | mutLBS | ZN | ZINC(2+) | 4tvr | A | C365 | ZN | ZINC(2+) | 1z6u | A | C733 C736 C756 | ZN | ZINC(2+) | 1z6u | B | C733 C736 C756 | ZN | ZINC(2+) | 1z6u | A | C771 | ZN | ZINC(2+) | 1z6u | B | C771 | ZN | ZINC(2+) | 4tvr | A | H370 |
| Top |
| Conservation information for LBS of UHRF2 |
| Multiple alignments for Q96PU4 in multiple species |
| LBS | AA sequence | # species | Species |
 |
Copyright © 2016-Present - The University of Texas Health Science Center at Houston |